Author | Year | Country | Design | No. Patient | Gender | Age, Year | time interval | No. lesion | Field Strength | b value | Blind | Reference Standard | ADC cut off value (×10−3 mm2/s) | Threshold used |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Afifi [9] | 2016 | Egypt | Pro | 20 | 18/2 | 56(42–69) | 3w | 20 | 1.5 T | 0, 300,600 | NR | follow up | NR | Visual |
Du [10] | 2014 | China | Re | 89 | 57/32 | 56.0(26–78) | 1mo | 113 | 1.5 T | 0,800 | NR | follow up | 1.54 | ADC |
Ebraheem [11] | 2017 | Egypt | Pro | 50 | 42/8 | 60(40–79) | NR | 50 | 1.5 T | 0,50,1000 | NR | follow up | NR | Visual |
Goshima [12] | 2008 | Japan | Re | 25 | 18/7 | 60(48–79) | 2-6mo | 39 | 1.5 T | 0,500 | Y | follow up | NR | Visual |
Hassan [13] | 2019 | USA | Re | 60 | 45/15 | 60(40–73) | NR | 63 | 1.5 T | 0,400,800 | NR | follow up | N | Visual |
Kokabi [14] | 2015 | Georgia | Pro | 57 | 39/18 | 61.3(25–82) | 3mo | 57 | 1.5 T | 50,400,800 | NR | follow up | 0.83 | ADC |
Li [15] | 2016 | China | Pro | 117 | 86/31 | 51.7(31–74) | 1mo | 117 | NR | NR | NR | follow up | 1.24 | ADC |
Mannelli [16] | 2009 | USA | Re | 21 | 19/2 | 57.7(30–70) | 10d-3mo | 28 | 1.5 T | 0,50,500 | Y | Patholoy | 2.16 | ADC |
Wu [17] | 2017 | China | Pro | 84 | 57/27 | 54.5(25–76) | 1mo-2mo | 84 | 1.5 T | 300,600,800 | NR | follow up | 1.20 | ADC |
Xiao [18] | 2008 | China | Re | 15 | 13/2 | 45.7(17–63) | 10d-2mo | 30 | 1.5 T | 0,500 | Y | patholoy | NR | Visual |
Yousef [19] | 2017 | Egypt | Pro | 45 | 38/7 | 59(38–75) | 3w-5 m | 59 | 1.5 T | 0,400,800 | NR | follow up | NR | Visual |
Yuan [20] | 2014 | China | Pro | 41 | 34/7 | 56.2(23–78) | 6w-8w | 52 | 1.5 T | 0,500 | Y | follow up | 1.84 | Visual |